Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc.
Case Number:
23-2254
Court:
Nature of Suit:
835 Patent - (ANDA) (Fed. Qst.)
Companies
- Aurobindo Pharma Ltd.
- Dr. Reddy's Laboratories Ltd.
- Fresenius Kabi AG
- Fresenius SE & Co. KGaA
- Gland Pharma Ltd.
- Lupin Ltd.
- Mankind Pharma Ltd.
- Merck & Co. Inc.
- Sandoz International GmbH
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
Sectors & Industries:
-
March 13, 2025
Fed. Circ. Sides With Merck In Reissued Patent Debate
The Federal Circuit isn't buying that a reissued patent was actually "issued" at the time it was originally awarded, dashing generic-drug makers' hopes of breaking pharmaceutical giant Merck's hold on a blockbuster drug that counteracts the effects of anesthesia.
-
February 04, 2025
Fed. Circ. Grapples With Extensions On Reissued Patents
The Federal Circuit is set to decide when a reissued patent actually expires after fielding arguments Tuesday morning from Merck and the generic-drug makers who are trying to break the pharmaceutical giant's hold on a blockbuster drug that counteracts the effects of anesthesia.
-
October 25, 2023
Drug Cos. Question When Reissued Patent Is Actually Issued
Generic drugmakers trying to break Merck's hold on a blockbuster anesthesia-reversing drug are telling the Federal Circuit that a New Jersey federal judge's idea of when a reissued patent is actually issued or expires is a "legal fiction" that goes against "basic precepts of English."